Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors.

about

Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors.

Item

http://www.wikidata.org/entity/Q47744626

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cannabinoid CB1 Discrimination ...... d Catabolic Enzyme Inhibitors.

@en

Cannabinoid CB1 Discrimination ...... d Catabolic Enzyme Inhibitors.

@nl

type

Item

label

Cannabinoid CB1 Discrimination ...... d Catabolic Enzyme Inhibitors.

@en

Cannabinoid CB1 Discrimination ...... d Catabolic Enzyme Inhibitors.

@nl

prefLabel

Cannabinoid CB1 Discrimination ...... d Catabolic Enzyme Inhibitors.

@en

Cannabinoid CB1 Discrimination ...... d Catabolic Enzyme Inhibitors.

@nl

P1476

Cannabinoid CB1 Discrimination ...... d Catabolic Enzyme Inhibitors.

@en

P2093

Brian D Kangas

http://www.w3.org/2001/XMLSchema#string

Jack Bergman

http://www.w3.org/2001/XMLSchema#string

Lipin Ji

http://www.w3.org/2001/XMLSchema#string

Michael Z Leonard

http://www.w3.org/2001/XMLSchema#string

Shakiru O Alapafuja

http://www.w3.org/2001/XMLSchema#string

Spyros P Nikas

http://www.w3.org/2001/XMLSchema#string

Vidyanand G Shukla

http://www.w3.org/2001/XMLSchema#string

Yingpeng Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes

Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice

Pharmacology and stereoselectivity of structurally novel cannabinoids in mice

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

Modulation of anxiety through blockade of anandamide hydrolysis

Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.

Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice

Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents

Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain

Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell.

P304

314-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.117.244392

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

363

http://www.w3.org/2001/XMLSchema#string

P50

Alexandros Makriyannis

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28947487

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoids

endocannabinoids

P932

5683067

http://www.w3.org/2001/XMLSchema#string